Fust Matthew K — insider trades
Stock trades Fust Matthew K reported on SEC Form 4 at CRNX Crinetics Pharmaceuticals, Inc..
- Sep 26, 2025: sold 16,000 shares of CRNX Crinetics Pharmaceuticals, Inc. ($716K)
Stock trades Fust Matthew K reported on SEC Form 4 at CRNX Crinetics Pharmaceuticals, Inc..